Affymax Announces Teleconference and Webcast
PALO ALTO, Calif. -- February 25, 2013
Affymax, Inc. (Nasdaq: AFFY) will host a teleconference and webcast at 5:30
a.m. Pacific Time; 8:30 a.m. Eastern Time today, February 25, to discuss the
voluntary recall of OMONTYS® (peginesatide) Injection. Interested parties can
listen to the live teleconference by dialing (866) 393-1565 from the U.S. or
+1(973) 409-9608 for international callers. Individuals may access the live
audio webcast by visiting www.affymax.com and going to the Investors section.
A replay of the webcast will be available on the company’s website for 30 days
following the live event.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California.
Affymax's mission is to discover, develop and deliver innovative therapies
that improve the lives of patients with kidney disease and other serious and
often life-threatening illnesses. For additional information on Affymax,
please visit www.affymax.com.
Sylvia Wheeler, 650-812-8861
Press spacebar to pause and continue. Press esc to stop.